On the recordMarch 12, 2019
When a company delays the start of the exclusivity period of a product, it not only delays other generics from coming to market, it also delays lower prices reaching patients sooner.
Source
congress.govWhen a company delays the start of the exclusivity period of a product, it not only delays other generics from coming to market, it also delays lower prices reaching patients sooner.
Eshoo discusses the impact of exclusivity delays on generic drug availability and pricing.
Share
More from Anna Eshoo
I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.
I thank the ranking member for yielding time to me, and I thank him for support of my bill, the Securing Semiconductor Supply Chains Act of 2023. My congressional district was named for the materials that semiconductors are made…
In 1997 this subcommittee held a joint hearing with the Senate Labor Committee to review our Nation's system for organ transplant.